Serum Iron Levels as a New Biomarker in Chemotherapy With Leucovorin and Fluorouracil Plus Oxaliplatin or Leucovorin and Fluorouracil Plus Irinotecan, With or Without Molecularly-Targeted Drugs
Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2013.136
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2013
Authors
Publisher
Spandidos Publications